LPS-induced dissociation of multidrug resistance-associated protein 2 (Mrp2) and radixin is associated with Mrp2 selective internalization in rats
Related Experiment Video
Updated: Jun 8, 2026

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
Published on: May 19, 2016
Junjiro Saeki1, Shuichi Sekine, Toshiharu Horie
1Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba, 260-8675, Japan.
Abstract:
Multidrug resistance-associated protein 2 (Mrp2) is an ATP-dependent export pump that mediates the formation of bile-salt-independent bile flow. Disruption of the canalicular localization of Mrp2, without changes in its expression, is observed in chronic liver failure and is accompanied by oxidative stress. We reported previously that Mrp2 is rapidly internalized from the canalicular membrane during acute oxidative stress induced by lipopolysaccharide (LPS) in the rat liver. A disturbance in the colocalization of Mrp2 and radixin (which crosslinks actin with interacting membrane proteins) and endocytic retrieval of Mrp2 are present in chronic liver failure. However, the C-terminal phosphorylation status of radixin (p-radixin; functional form) and its protein-protein interaction with Mrp2 were not examined in the pathological cholestatic situation. In this study, we examined whether the C-terminal phosphorylation status of radixin and its interaction with Mrp2 were affected by LPS-induced experimental liver failure with cholestasis, and whether this condition was accompanied by Mrp2 internalization in the rat liver. At 3h after LPS treatment, the canalicular expression of Mrp2 was decreased, without variation of the other canalicular transporters. Similarly, the canalicular localization of radixin was decreased after LPS treatment. These results show that LPS treatment decreased the total amount of the active form of p-radixin and the amount of radixin that coimmunoprecipitated with Mrp2, and that LPS treatment impaired the protein-protein interaction between Mrp2 and radixin. In conclusion, LPS-induced cholestasis seems to be caused by posttranscriptional regulation of Mrp2, which is due to the disruption of its interaction with radixin and by its dephosphorylation.
Insights
Lipopolysaccharide (LPS) causes liver injury by disrupting the interaction between multidrug resistance-associated protein 2 (Mrp2) and radixin, leading to Mrp2 internalization and cholestasis.
Area of Science:
- Hepatology
- Cell Biology
- Biochemistry
Background:
- Multidrug resistance-associated protein 2 (Mrp2) is crucial for bile flow, and its disruption is linked to liver failure and oxidative stress.
- Previous studies showed Mrp2 internalization during acute oxidative stress and impaired colocalization with radixin in chronic liver failure.
Purpose of the Study:
- To investigate the effect of lipopolysaccharide (LPS)-induced liver failure on radixin phosphorylation and its interaction with Mrp2.
- To determine if LPS-induced cholestasis involves Mrp2 internalization via changes in radixin interaction and phosphorylation.
Main Methods:
- Rats were treated with LPS to induce experimental liver failure and cholestasis.
- Changes in canalicular expression of Mrp2 and radixin were assessed.
- C-terminal phosphorylation of radixin (p-radixin) and its co-immunoprecipitation with Mrp2 were analyzed.
Main Results:
- LPS treatment reduced canalicular Mrp2 and radixin expression.
- The amount of active p-radixin and radixin co-immunoprecipitating with Mrp2 decreased after LPS treatment.
- LPS impaired the protein-protein interaction between Mrp2 and radixin.
Conclusions:
- LPS-induced cholestasis in rats is associated with decreased Mrp2 canalicular localization.
- Disruption of the Mrp2-radixin interaction and radixin dephosphorylation contribute to Mrp2 internalization.
- These findings suggest posttranscriptional regulation of Mrp2 in LPS-induced liver injury.
More Related Videos
10:43Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
Published on: December 3, 2010
16:26Setting-up an In Vitro Model of Rat Blood-brain Barrier (BBB): A Focus on BBB Impermeability and Receptor-mediated Transport
Published on: June 28, 2014
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...